Respiratory Diseases
Breathing life into innovation for patients with chronic and acute respiratory conditions. At Innoclin Research, we recognize the profound impact respiratory diseases have on patients’ quality of life and healthcare systems worldwide. From common conditions like asthma and COPD to rare pulmonary disorders and acute respiratory infections, our goal is to deliver studies that lead to safer, faster, and more effective therapies.
Respiratory Diseases Research
Advanced clinical solutions for complex respiratory conditions, from asthma to rare lung diseases
Patient-Centered Solutions
Respiratory diseases often involve fluctuating symptoms, environmental triggers, and overlapping comorbidities. We design trials that capture the real-world variability of respiratory illness through advanced digital spirometry, wearable monitoring devices, and longitudinal patient-reported outcomes.
Advanced Monitoring
Real-world data for better outcomes
Enhanced Trial Accessibility
Respiratory patients often face mobility and travel challenges. To address this, we integrate home health visits, decentralized trial technologies, and remote pulmonary function testing into study designs. This not only improves patient retention but also reflects the real-world use of therapies.
Regulatory & Safety Expertise
Our regulatory experts are adept at navigating evolving guidance on inhaled medicines, biologics, and advanced therapies for respiratory diseases. From device-related safety to long-term monitoring of pulmonary function, we prioritize patient safety while expediting regulatory approvals.
Our teams support clinical development across:
Asthma & COPD
Biologics, inhaled therapies, and combination treatments.
Pulmonary Hypertension
Targeted vasodilator therapies and novel molecular agents.
Cystic Fibrosis & Rare Diseases
Specialized endpoints and long-term registries.
Acute Respiratory Infections
Influenza, COVID-19, RSV - antivirals and vaccines.
Leveraging expertise from other therapeutic areas:
Cardiology
Cardiovascular comorbidities in COPD and pulmonary hypertension.
Infectious Diseases
Respiratory support in viral pneumonia and pandemic studies.
Pediatrics
Age-appropriate endpoints in pediatric asthma and cystic fibrosis.
Ready to Breathe Better?
Let's discuss your respiratory clinical research needs.
